Bisindolylmaleimide VIII (acetate)
| 规格 | 价格 | 货期 | 数量 |
|---|---|---|---|
| 5mg | 请咨询 | 10-15工作日发货 | |
| 10mg | 请咨询 | 10-15工作日发货 |
特色产品
- 用于免疫印迹和质谱分析等后续操作
- 适用于30 KDa-130 KDa大小的蛋白
- 可将信号灵敏度提高100倍
- 同时保持稳定的特异性和分辨率
- 提供更高的转录效率并抑制免疫激活
- 使用5-moUTP和Cy5-utp修饰
产品描述
IC50: 158 nM for rat brain PKC
Bisindolylmaleimide VIII is a protein kinase C (PKC) inhibitor.
The protein kinase C (PKC) consists of a family of closely related isoenzymes mediating various signal transduction processes. The ten isoenzymes that have been currently identified can be divided into three families on the basis of their different requirements for activation. Members of the conventional PKC family are Ca2+ and phospholipid-dependent and are activated by diacylglycerols and phorbol esters.
In vitro: Previous study found that bisindolylmaleimides carrying a straight-chain alkyl side-chain bearing a cationic substituent, such as Ro 31-7549 (bisindolylmaleimide VIII) and Ro 31-8220, showed a significant improvement in potency over the simple bisindolylmaleimides. For bisindolylmaleimide VIII, a further improvement in potency was obtained by restricting the position of the amine substituent. Moreove, unlike the indolocarbazole, staurosporine, which displayed 2-fold selectivity for PKC-β over the other examined isoenzymes, bisindolylmaleimide VIII exhibited a slight selectivity for PKC-α over the other isoenzymes. Compounds such as bisindolylmaleimide VIII carrying a straight-chain alkyl side-chain with the cationic substituent were found to be equipotent as inhibitors of PKC-β, PKC-γ and PKC-ε [1].
In vivo: Animal study found that, in neonatal rats, high glucose levels could induce the hypertrophy of cardiomyocytes. Ro-31-8220, a analog of bisindolylmaleimide VIII, was able to reverse the effect of high glucose on the cardiac myocytes,which might be through PKC/NF-κB/c-Fos pathway [2].
Clinical trial: So far, no clinical study has been conducted.
References:
[1] Wilkinson, S. E.,Parker, P.J. and Nixon, J.S. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochemistry Journal 294, 335-337 (1993).
[2] Zhang, W. B. et al. Reverse effect of protein kinase C inhibitor Ro-31-8220 on the hypertrophy of cardiomyocytes of neonatal rats induced by high glucose levels. Chinese Journal of Pathophysiology. 2009-08.
产品性质
| 物理外观 | Solid |
| CAS号 | 138516-31-1 |
| 分子式 | C24H22N4O2·C2H4O2 |
| 分子量 | 458.5 |
| 小分子别名 | Bisindolylmaleimide VIII acetate |
| 化学名称 | 3-[1-(3-aminopropyl)-1H-indol-3-yl]-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, acetate |
| 溶解度 | Soluble in DMSO |
| SMILES | CC(O)=O.C[n]1c(cccc2)c2c(C(C(N2)=O)=C(c3c[n](CCCN)c4c3cccc4)C2=O)c1 |
| 存储条件 | -20°C |
| 运输条件 | 蓝冰 |
产品应用 (实验数据来自文献,APExBIO并未验证,仅供参考)
IC50和靶点
| 生物活性描述 | 双吲哚马来酰亚胺醋酸盐 VIII(Ro 31-7549 醋酸盐)是一种强效的选择性蛋白激酶 C(PKC)抑制剂,对大鼠脑 PKC 的 IC50 值为 158 nM。双吲哚马来酰亚胺醋酸盐 VIII 对 PKC-α、PKC-βI、PKC-βII、PKC-γ、PKC-ε 的 IC50 分别为 53、195、163、213 和 175 nM。醋酸双吲哚马来酰亚胺 VIII 可促进 Fas 介导的细胞凋亡,抑制 T 细胞介导的自身免疫性疾病。 |



沪公网安备 31011002003500